Ziconotide Acetate

CHEMBL1795072 Phase 4 ได้รับการอนุมัติ Protein
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

Ziconotide acetate is the acetate salt form of ziconotide, a selective N-type voltage-gated calcium channel blocker derived from cone snail venom used for intrathecal treatment of severe chronic pain. The acetate salt form is used in the aqueous solution for intrathecal infusion via implanted drug delivery systems. Like the parent compound, it inhibits presynaptic calcium influx in dorsal horn neurons, preventing neurotransmitter release and pain signal transmission.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

Ziconotide acetate is the acetate salt form of ziconotide, a selective N-type voltage-gated calcium channel blocker derived from cone snail venom used for intrathecal treatment of severe chronic pain. The acetate salt form is used in the aqueous solution for intrathecal infusion via implanted drug delivery systems. Like the parent compound, it inhibits presynaptic calcium influx in dorsal horn neurons, preventing neurotransmitter release and pain signal transmission.

Yes, Ziconotide Acetate is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1795072. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.